36.80
36.80 (0%)
As of Apr 17, 2025
Twist Bioscience Corp [TWST]
Source:
Company Overview
Twist Bioscience Corp is a leading, rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology.
| Country | United States |
| Headquarters | south san francisco, california |
| Phone Number | 800-719-0671 |
| Industry | manufacturing |
| CEO | Emily M. Leproust |
| Website | www.twistbioscience.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $88.7 |
| Operating Profit | $-34.6 |
| Net Income | $-31.6 |
| Net Cash | $-5.1 |
Profit Ratios
| Gross Margin | $42.8 |
| Operating Margin | -39.1 |
| Profit as % of Revenues | -135.6% |
| Profit as % of Assets | -5.2% |
| Profit as % of Stockholder Equity | -6.9% |
Management Effectiveness
| Return on Equity | -6.9% |
| Return on Assets | -5.2% |
| Turnover Ratio | 14.5% |
| EBITA | $-34.6 |
Balance Sheet and Cash Flow Measures
| Total Assets | $608.6 |
| Total Liabilities | $152.6 |
| Operating Cash Flow | $-21.4 |
| Investing Cash Flow | $-1.5 |
| Financing Cash Flow | $17.9 |
